Detalhe da pesquisa
1.
Differentiation between early rheumatoid and early psoriatic arthritis by the ultrasonographic study of the synovio-entheseal complex of the small joints of the hands.
Clin Exp Rheumatol
; 34(3): 459-65, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-26939710
2.
Efficacy of belimumab and targeting of rheumatoid factor-positive B-cell expansion in Sjögren's syndrome: follow-up after the end of the phase II open-label BELISS study.
Clin Exp Rheumatol
; 34(2): 311-4, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-26886154
3.
Efficacy and safety of belimumab in primary Sjögren's syndrome: results of the BELISS open-label phase II study.
Ann Rheum Dis
; 74(3): 526-31, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-24347569
4.
Efficacy and safety of belimumab given for 12 months in primary Sjögren's syndrome: the BELISS open-label phase II study.
Rheumatology (Oxford)
; 54(12): 2249-56, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26242856
5.
The 158VV Fcgamma receptor 3A genotype is associated with response to rituximab in rheumatoid arthritis: results of an Italian multicentre study.
Ann Rheum Dis
; 73(4): 716-21, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-23505228
6.
Biomarkers of lymphoma in Sjögren's syndrome and evaluation of the lymphoma risk in prelymphomatous conditions: results of a multicenter study.
J Autoimmun
; 51: 75-80, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24231556
7.
Sequential therapy with belimumab followed by rituximab in Sjögren's syndrome associated with B-cell lymphoproliferation and overexpression of BAFF: evidence for long-term efficacy.
Clin Exp Rheumatol
; 32(4): 490-4, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24802131
8.
High prevalence of Chlamydophila psittaci subclinical infection in Italian patients with Sjögren's syndrome and parotid gland marginal zone B-cell lymphoma of MALT-type.
Clin Exp Rheumatol
; 32(1): 61-5, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24447326
9.
The TTTT B lymphocyte stimulator promoter haplotype is associated with good response to rituximab therapy in seropositive rheumatoid arthritis resistant to tumor necrosis factor blockers.
Arthritis Rheum
; 65(1): 88-97, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-23001900
10.
BLyS upregulation in Sjogren's syndrome associated with lymphoproliferative disorders, higher ESSDAI score and B-cell clonal expansion in the salivary glands.
Rheumatology (Oxford)
; 52(2): 276-81, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-22879463
11.
Cryoglobulinaemia related to Sjogren's syndrome or HCV infection: differences based on the pattern of bone marrow involvement, lymphoma evolution and laboratory tests after parotidectomy.
Rheumatology (Oxford)
; 51(4): 627-33, 2012 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-22210656
12.
Rheumatoid factor positivity rather than anti-CCP positivity, a lower disability and a lower number of anti-TNF agents failed are associated with response to rituximab in rheumatoid arthritis.
Rheumatology (Oxford)
; 48(12): 1557-9, 2009 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-19789202
13.
Pleuritis is a red flag for adult-onset Still's disease which may require biologic therapies.
Clin Exp Rheumatol
; 30(5): 807, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22992345
14.
Controversies on rituximab therapy in sjögren syndrome-associated lymphoproliferation.
Int J Rheumatol
; 2009: 424935, 2009.
Artigo
em Inglês
| MEDLINE | ID: mdl-20148068